Table 4.
Activated phenotype of T lymphocytes during graft-versus-host disease (GvHD) (samples group II).
| CD4 | CD8 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GvHD Pa | Days post-transplant | CD25+ | CD69+ | DR+ | CD134+ | CD154+ | CD25+ | CD69+ | DR+ | CD134+ | CD154+ |
| 1 | 64 | n.d.b | 2·5 | 29·9 | 11·4 | 0·7 | 8·4 | 2·42 | 12·0 | 2·58 | 0·46 |
| 2 | 27 | 54·4c | 14·6 | 21·5 | 35·9 | 9·2 | 12·9 | 15·1 | 3·41 | 7·03 | 3·79 |
| 3 | 14 | 44·7 | 10·9 | 15·8 | 25·4 | 10·5 | 9·53 | 9·81 | 1·54 | 6·54 | 3·96 |
| 4 | 70 | 19·0 | 3·9 | 7·2 | 7·3 | 2·2 | 9·4 | 6·47 | 1·21 | 2·66 | 1·28 |
| 5 | 11 | 57·0 | 20·0 | 7·3 | 21·0 | 0·8 | 19·4 | 24·4 | 17·1 | 12·2 | n.d. |
| 6 | 14 | 48·6 | 1·28 | 18·0 | 15·2 | 17·8 | 42·0 | 2·44 | 23·0 | 9·7 | 2·56 |
| 7 | 45 | 42·5 | 22·2 | 28·8 | 25·3 | 6·8 | 12·1 | 13·5 | 35·2 | 10·2 | 6·71 |
| 8 | 28 | 35·0 | 4·6 | 53·1 | 21·0 | n.d. | 17·0 | 6·37 | 68·3 | 4·7 | 2·45 |
| 9 | 18 | 30·0 | 5·4 | 29·0 | 22·6 | 6·6 | 5·88 | 25·7 | 20·0 | 11·8 | 11·8 |
| Healthy donorsd | 4·3 ± 1·2 | 1·6 ± 1·4 | 2·1 ± 0·9 | 2·1 ± 0·4 | 0·1 ± 0·1 | 2·12 +1·6 | 2·29 +2·1 | 0·3 +0·09 | 0·6 ± 0·4 | 0·11 ± 0·2 | |
a
Patient numbers correspond to the numbers shown inTable 2
b
n.d. not determined
c
data are shown as percentage. Bold numbers indicated those percentages higher than 2 (mean ± s.d.) values of healthy donors
d
values are shown as mean ± s.d. of 15 healthy donors.